A trial of agonistic anti-CD40 antibody: Biological effects in a Cancer Research UK phase I study.

Category Primary study
JournalCANCER RESEARCH
Year 2013
This article has no abstract
Epistemonikos ID: a3d03ac74538b4d3ce910048807f932db2154a4a
First added on: Feb 05, 2025